These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9373789

  • 21. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 22. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 30; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 23. Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
    Chapman TM, Perry CM.
    Am J Respir Med; 2003 Jan 30; 2(1):75-107. PubMed ID: 14720024
    [Abstract] [Full Text] [Related]

  • 24. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX, Neu HC.
    Chemioterapia; 1987 Oct 30; 6(5):329-36. PubMed ID: 3322588
    [Abstract] [Full Text] [Related]

  • 25. In vitro activity of cefepime, a new parenteral cephalosporin, against recent European blood isolates and in comparison with piperacillin/tazobactam.
    Dornbusch K, Mörtsell E, Göransson E.
    Chemotherapy; 1990 Oct 30; 36(4):259-67. PubMed ID: 2174761
    [Abstract] [Full Text] [Related]

  • 26. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
    King A, Boothman C, Phillips I.
    Eur J Clin Microbiol Infect Dis; 1990 Sep 30; 9(9):677-85. PubMed ID: 2226498
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group.
    Biedenbach DJ, Lewis MT, Jones RN.
    Diagn Microbiol Infect Dis; 1999 Dec 30; 35(4):277-83. PubMed ID: 10668586
    [Abstract] [Full Text] [Related]

  • 33. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ, Wang H, China Nosocomial Pathogens Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):375-81. PubMed ID: 12820912
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
    Triantafilo V, Fica A, Silva M, Thompson L.
    Rev Med Chil; 1997 Feb 10; 125(2):149-60. PubMed ID: 9430934
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.